ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Adeptio Pharmaceuticals Ltd

Adeptio Pharmaceuticals Ltd is an active company incorporated on 29 October 2009 with the registered office located in London, Greater London. Adeptio Pharmaceuticals Ltd was registered 16 years ago.
Status
Active
Active since 14 years ago
Company No
07060603
Private limited company
Age
16 years
Incorporated 29 October 2009
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Due Soon
Dated 3 February 2025 (12 months ago)
Next confirmation dated 3 February 2026
Due by 17 February 2026 (15 days remaining)
Last change occurred 11 months ago
Accounts
Submitted
For period 1 Jul30 Jun 2025 (12 months)
Accounts type is Small
Next accounts for period 30 June 2026
Due by 31 March 2027 (1 year 1 month remaining)
Contact
Address
Suite1, 7th Floor 50 Broadway
London
SW1H 0BL
England
Address changed on 19 Oct 2022 (3 years ago)
Previous address was Suite 1, 3rd Floor, 11-12 st. James's Square London SW1Y 4LB England
Telephone
07944614087
Email
Available in Endole App
People
Officers
4
Shareholders
12
Controllers (PSC)
2
Director • British • Lives in England • Born in Feb 1954
Director • British • Lives in England • Born in Oct 1956
Director • British • Lives in Bermuda • Born in Oct 1934
Finisterre UK Foundation Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Horizon Pharmaceuticals Limited
Anant Kumar Pandya is a mutual person.
Active
Cidrew Limited
Andrew John Duffield is a mutual person.
Active
Synergy Pharma Consulting Limited
Anant Kumar Pandya is a mutual person.
Active
Twenty Sixteen (2016) Pharma Limited
Anant Kumar Pandya is a mutual person.
Active
Transdermal Limited
Anant Kumar Pandya is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2025)
Period Ended
30 Jun 2025
For period 30 Jun30 Jun 2025
Traded for 12 months
Cash in Bank
£2.58M
Decreased by £1.04M (-29%)
Turnover
Unreported
Same as previous period
Employees
6
Same as previous period
Total Assets
£2.84M
Decreased by £809K (-22%)
Total Liabilities
-£20.18M
Increased by £1.85M (+10%)
Net Assets
-£17.34M
Decreased by £2.66M (+18%)
Debt Ratio (%)
711%
Increased by 208.43% (+41%)
Latest Activity
Small Accounts Submitted
16 Days Ago on 16 Jan 2026
Francine Michelle Mason (PSC) Appointed
19 Days Ago on 13 Jan 2026
Francine Michelle Mason (PSC) Resigned
19 Days Ago on 13 Jan 2026
Mr Andrew John Duffield Appointed
2 Months Ago on 30 Nov 2025
Mark Price Evans Resigned
2 Months Ago on 30 Nov 2025
Mr Anant Kumar Pandya Appointed
2 Months Ago on 30 Nov 2025
Confirmation Submitted
11 Months Ago on 20 Feb 2025
Small Accounts Submitted
1 Year 1 Month Ago on 12 Dec 2024
Small Accounts Submitted
1 Year 8 Months Ago on 4 Jun 2024
Confirmation Submitted
1 Year 11 Months Ago on 23 Feb 2024
Get Credit Report
Discover Adeptio Pharmaceuticals Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Accounts for a small company made up to 30 June 2025
Submitted on 16 Jan 2026
Notification of Francine Michelle Mason as a person with significant control on 13 January 2026
Submitted on 15 Jan 2026
Cessation of Francine Michelle Mason as a person with significant control on 13 January 2026
Submitted on 15 Jan 2026
Appointment of Mr Andrew John Duffield as a director on 30 November 2025
Submitted on 4 Dec 2025
Termination of appointment of Mark Price Evans as a director on 30 November 2025
Submitted on 4 Dec 2025
Appointment of Mr Anant Kumar Pandya as a director on 30 November 2025
Submitted on 4 Dec 2025
Confirmation statement made on 3 February 2025 with updates
Submitted on 20 Feb 2025
Accounts for a small company made up to 30 June 2024
Submitted on 12 Dec 2024
Resolutions
Submitted on 4 Dec 2024
Memorandum and Articles of Association
Submitted on 4 Dec 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year